474 related articles for article (PubMed ID: 8718432)
1. Raised serum sialic acid concentration in NIDDM patients with and without diabetic nephropathy.
Chen J; Gall MA; Yokoyama H; Jensen JS; Deckert M; Parving HH
Diabetes Care; 1996 Feb; 19(2):130-4. PubMed ID: 8718432
[TBL] [Abstract][Full Text] [Related]
2. Elevated serum sialic acid concentration in NIDDM and its relationship to blood pressure and retinopathy.
Crook MA; Tutt P; Pickup JC
Diabetes Care; 1993 Jan; 16(1):57-60. PubMed ID: 8422833
[TBL] [Abstract][Full Text] [Related]
3. Raised serum sialic acid concentration precedes onset of microalbuminuria in IDDM. A 10-year follow-up study.
Yokoyama H; Jensen JS; Myrup B; Mathiesen ER; Rønn B; Deckert T
Diabetes Care; 1996 May; 19(5):435-40. PubMed ID: 8732705
[TBL] [Abstract][Full Text] [Related]
4. Fasting and post-methionine homocysteine levels in NIDDM. Determinants and correlations with retinopathy, albuminuria, and cardiovascular disease.
Smulders YM; Rakic M; Slaats EH; Treskes M; Sijbrands EJ; Odekerken DA; Stehouwer CD; Silberbusch J
Diabetes Care; 1999 Jan; 22(1):125-32. PubMed ID: 10333913
[TBL] [Abstract][Full Text] [Related]
5. Urinary albumin excretion as a predictor of diabetic retinopathy, neuropathy, and cardiovascular disease in NIDDM.
Savage S; Estacio RO; Jeffers B; Schrier RW
Diabetes Care; 1996 Nov; 19(11):1243-8. PubMed ID: 8908388
[TBL] [Abstract][Full Text] [Related]
6. Macro-microangiopathy and endothelial dysfunction in NIDDM patients with and without diabetic nephropathy.
Parving HH; Nielsen FS; Bang LE; Smidt UM; Svendsen TL; Chen JW; Gall MA; Rossing P
Diabetologia; 1996 Dec; 39(12):1590-7. PubMed ID: 8960847
[TBL] [Abstract][Full Text] [Related]
7. Serum sialic acid, a risk factor for cardiovascular disease, is increased in IDDM patients with microalbuminuria and clinical proteinuria.
Crook MA; Earle K; Morocutti A; Yip J; Viberti G; Pickup JC
Diabetes Care; 1994 Apr; 17(4):305-10. PubMed ID: 8026286
[TBL] [Abstract][Full Text] [Related]
8. Serum sialic acid concentration is elevated in IDDM especially in early diabetic nephropathy.
Yokoyama H; Jensen JS; Jensen T; Deckert T
J Intern Med; 1995 May; 237(5):519-23. PubMed ID: 7738493
[TBL] [Abstract][Full Text] [Related]
9. Relation of serum total sialic acid concentrations with diabetic complications and cardiovascular risk factors in Kuwaiti Type 2 diabetic patients.
Abdella N; Akanji AO; Mojiminiyi OA; Al Assoussi A; Moussa M
Diabetes Res Clin Pract; 2000 Sep; 50(1):65-72. PubMed ID: 10936670
[TBL] [Abstract][Full Text] [Related]
10. Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease?
Chico A; Pérez A; Córdoba A; Arcelús R; Carreras G; de Leiva A; González-Sastre F; Blanco-Vaca F
Diabetologia; 1998 Jun; 41(6):684-93. PubMed ID: 9662051
[TBL] [Abstract][Full Text] [Related]
11. Increased plasma apolipoprotein (a) levels in IDDM patients with diabetic nephropathy.
Tarnow L; Rossing P; Nielsen FS; Hansen BV; Dyerberg J; Parving HH
Diabetes Care; 1996 Dec; 19(12):1382-7. PubMed ID: 8941468
[TBL] [Abstract][Full Text] [Related]
12. Relationship between plasma sialic acid concentration and microvascular and macrovascular complications in type 1 diabetes: the EURODIAB Complications Study.
Crook MA; Pickup JC; Lumb PJ; Giorgino F; Webb DJ; Fuller JH;
Diabetes Care; 2001 Feb; 24(2):316-22. PubMed ID: 11213885
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein(a) and cardiovascular disease in type 2 (non-insulin-dependent) diabetic patients with and without diabetic nephropathy.
Nielsen FS; Voldsgaard AI; Gall MA; Rossing P; Hommel E; Andersen P; Dyerberg J; Parving HH
Diabetologia; 1993 May; 36(5):438-44. PubMed ID: 8314449
[TBL] [Abstract][Full Text] [Related]
14. The urinary concentration of sialic acid is increased in non-insulin-dependent diabetic patients with microangiopathy: a possible useful marker for diabetic microangiopathy.
Suzuki K; Ishida H; Sugimoto C; Taguchi Y; Matsuda H; Nosaka K; Someya Y; Kadowaki S; Seino Y
Diabet Med; 1995 Dec; 12(12):1092-6. PubMed ID: 8750219
[TBL] [Abstract][Full Text] [Related]
15. Serum sialic acid concentration and coronary heart disease in NIDDM.
Pickup JC; Mattock MB; Crook MA; Chusney GD; Burt D; Fitzgerald AP
Diabetes Care; 1995 Aug; 18(8):1100-3. PubMed ID: 7587844
[TBL] [Abstract][Full Text] [Related]
16. Ethnic differences in correlates of microalbuminuria in NIDDM. The role of the acute-phase response.
Islam N; Kazmi F; Chusney GD; Mattock MB; Zaini A; Pickup JC
Diabetes Care; 1998 Mar; 21(3):385-8. PubMed ID: 9540020
[TBL] [Abstract][Full Text] [Related]
17. Incipient and overt diabetic nephropathy in African Americans with NIDDM.
Dasmahapatra A; Bale A; Raghuwanshi MP; Reddi A; Byrne W; Suarez S; Nash F; Varagiannis E; Skurnick JH
Diabetes Care; 1994 Apr; 17(4):297-304. PubMed ID: 8026285
[TBL] [Abstract][Full Text] [Related]
18. Elevated plasma asymmetric dimethylarginine as a marker of cardiovascular morbidity in early diabetic nephropathy in type 1 diabetes.
Tarnow L; Hovind P; Teerlink T; Stehouwer CD; Parving HH
Diabetes Care; 2004 Mar; 27(3):765-9. PubMed ID: 14988299
[TBL] [Abstract][Full Text] [Related]
19. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study.
Ohkubo Y; Kishikawa H; Araki E; Miyata T; Isami S; Motoyoshi S; Kojima Y; Furuyoshi N; Shichiri M
Diabetes Res Clin Pract; 1995 May; 28(2):103-17. PubMed ID: 7587918
[TBL] [Abstract][Full Text] [Related]
20. The association between retinopathy, nephropathy, cardiovascular disease and long-term metabolic control in type 1 diabetes mellitus: a 5 year follow-up study of 442 adult patients in routine care.
Agardh CD; Agardh E; Torffvit O
Diabetes Res Clin Pract; 1997 Mar; 35(2-3):113-21. PubMed ID: 9179466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
